Legal & General Group’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,063
| Closed | -$8.08K | – | 3438 |
|
|
2025
Q1 | $8.08K | Hold |
5,063
| – | – | ﹤0.01% | 3215 |
|
|
2024
Q4 | $18.2K | Hold |
5,063
| – | – | ﹤0.01% | 3053 |
|
|
2024
Q3 | $28.9K | Hold |
5,063
| – | – | ﹤0.01% | 2910 |
|
|
2024
Q2 | $23.3K | Buy |
+5,063
| New | +$23.3K | ﹤0.01% | 2960 |
|
|
2023
Q2 | – | Sell |
-5,591
| Closed | -$17.6K | – | 3429 |
|
|
2023
Q1 | $17.6K | Sell |
5,591
-7,844
| -58% | -$24.6K | ﹤0.01% | 3101 |
|
|
2022
Q4 | $79.3K | Buy |
13,435
+1,072
| +9% | +$6.33K | ﹤0.01% | 2866 |
|
|
2022
Q3 | $109K | Buy |
12,363
+1,017
| +9% | +$8.97K | ﹤0.01% | 2793 |
|
|
2022
Q2 | $86K | Buy |
11,346
+3,755
| +49% | +$28.5K | ﹤0.01% | 2894 |
|
|
2022
Q1 | $185K | Sell |
7,591
-24
| -0.3% | -$585 | ﹤0.01% | 2699 |
|
|
2021
Q4 | $245K | Buy |
7,615
+524
| +7% | +$16.9K | ﹤0.01% | 2630 |
|
|
2021
Q3 | $317K | Buy |
7,091
+2,520
| +55% | +$113K | ﹤0.01% | 2549 |
|
|
2021
Q2 | $173K | Buy |
4,571
+3,477
| +318% | +$132K | ﹤0.01% | 2576 |
|
|
2021
Q1 | $40K | Sell |
1,094
-44
| -4% | -$1.61K | ﹤0.01% | 2889 |
|
|
2020
Q4 | $38K | Buy |
+1,138
| New | +$38K | ﹤0.01% | 2874 |
|